How brain stem cells stay dormant and healthy as we age

Molecular mechanisms underlying the preservation of neural stem cell quiescence during aging

NIH-funded research Buck Institute for Research on Aging · NIH-11297611

This project looks at why the brain’s stem cells stop making new neurons with age and seeks ways to keep them healthy for people with age-related memory problems like Alzheimer’s.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionBuck Institute for Research on Aging NIH-funded
Lab location1 site (Novato, United States)
Project IDNIH-11297611 on NIH RePORTER

What this research studies

From your point of view, researchers are studying the brain’s neural stem cells to understand why they become less able to make new neurons as we get older. They focus on cell energy systems and mitochondrial cleanup (called mitophagy) and use combined gene, epigenetic, and metabolic analyses (multi-omics) to find what changes with age. Experiments use lab-grown cells and animal models and may include comparison with human-derived samples to pinpoint the key genes and pathways involved. The goal is to identify targets that could be used in future therapies to restore neuron formation and support memory and mood in aging and Alzheimer’s disease.

Who could benefit from this research

Good fit: Ideal candidates for related future studies or sample-donation efforts would be older adults, including people with mild cognitive impairment or early-stage Alzheimer’s disease, willing to provide samples or participate in follow-up clinical work.

Not a fit: People with advanced, late-stage dementia or unrelated medical conditions are unlikely to directly benefit from this basic research in the near term.

Why it matters

Potential benefit: If successful, this work could point to new ways to restore the brain’s ability to make neurons and potentially improve memory, mood, or cognitive decline in older adults and people with Alzheimer’s.

How similar studies have performed: Previous lab and animal studies have suggested that targeting metabolism and epigenetic factors can revive aspects of neurogenesis, but translating those findings into proven treatments for people remains largely unproven.

Where this research is happening

Novato, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's Disease
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.